Bölüm notları
Cannabis policy in the United States has been, in many ways, a giant experiment. The drug was recently reclassified by the Trump administration from a Schedule I to a Schedule III drug, but remains federally illegal. On the state level, cannabis’s availability to patients and consumers has been determined by voters, not by scientists and regulators. Each state has a different approach to cannabis regulation and product safety, and as a result, a patient using medical cannabis in Florida might be exposed to different risks than a consumer in California, for example.
On this episode, host…
Web sitesi: podcasters.spotify.com

